Delivery Order SPE2DB22D3501-SPE2DB24FTV84
Award Date 12/13/23
Potential Completion Date 12/14/23
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,111.77 for MULTIHANCE 529MG/ML 5S, a contrast agent pharmaceutical product, by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This firm fixed price, non-competitive set-aside delivery order is due for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,709.08 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 15 mmol/15 ml vials of Gadavist contrast agent. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 24, 2023. No set-aside designation was applied. As a prime contractor supporting DLA medical supply programs,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,666.54 to AmerisourceBergen Drug Corp for the supply of Multihance 529mg/ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price delivery order, issued on October 24, 2025, with an ultimate completion date of November 21, 2025, represents a non-competitive award under an existing indefinite delivery contract. The product will be delivered to the company's corporate office location in...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,653.20 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 10 vials of Gadavist 10 mmol/10 ml contrast agent. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 30, 2023. No set-aside designation was applied to this order, which was issued against an existing...
- Amerisourcebergen Drug Corp has received a $5,195.20 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 7.5 mmol/7.5 ml vials of Gadavist contrast agent. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to support military treatment programs from its headquarters in Conshohocken, Pennsylvania by November 29, 2023. No set-aside designation was applied to this award issued against an existing DLA contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA). The $6,325.24 delivery order, issued on December 13, 2023 with a completion date of December 14, 2023, is for the supply of 100mL bottles of the contrast agent Visipaque 320 mg/ml to support DLA Troop Support Medical programs....
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,910.04 to supply 30 milliliter vials of Gadavist, a 1 millimolar per milliliter bulk pharmaceutical product. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania with completion by November 29, 2023. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical supplies in support of DLA's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (10 ml) valued at $2,203.22 under a firm fixed price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,875.49 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 20 vials of DOTAREM 10 MMOL/20 ML contrast media. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with all supplies delivered by November 28, 2023. No set-aside designation was applied to this order, which was issued against an existing...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation operating through its Corporate Office division, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA). The $17,364 delivery order is for the supply of 100ml bottles of the contrast agent Iodixanol 320mg/ml to support DLA Troop Support Medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken,...